These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36987730)

  • 1. [CD7 CAR-T cells treat T-ALL relapsed after allogeneic hematopoietic stem cell transplantation: a case report].
    Huang HJ; Liu D; Wu YB; Jiang SS; Wu YX; Hou MJ; Hu XH; Ma X
    Zhonghua Xue Ye Xue Za Zhi; 2023 Jan; 44(1):79. PubMed ID: 36987730
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-Derived CD7 CAR-T Therapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Acute T-Lymphocytic Leukemia Associated With Hepatitis B: A Case Report.
    Li Z; Meng F; Li J; Wu T
    Front Immunol; 2022; 13():931452. PubMed ID: 35903089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Allogeneic hematopoietic stem cell transplantation combined with CD7 CAR-T for the treatment of T lymphoblastic lymphoma: a case report and literature review].
    Wang XM; Zhou Y; Zhang JL; Zhou HY; Zhang Q; Sun Q; Li HJ; Xu LY; Yao SN; Yao ZH; Yan DM; Xu KL; Sang W
    Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):864-865. PubMed ID: 38049342
    [No Abstract]   [Full Text] [Related]  

  • 4. Donor-derived CAR-T Cells Serve as a Reduced-intensity Conditioning Regimen for Haploidentical Stem Cell Transplantation in Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: Case Report and Review of the Literature.
    Zhang C; Kong PY; Li S; Chen T; Ni X; Li Y; Wang M; Liu Y; Gao L; Gao L; Peng XG; Sun AH; Wang P; Yang Z; Zhang X; Qian C
    J Immunother; 2018; 41(6):306-311. PubMed ID: 29864079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAR-T cells and allogeneic hematopoietic stem cell transplantation for relapsed/refractory B-cell acute lymphoblastic leukemia.
    Liu J; Zhang X; Zhong JF; Zhang C
    Immunotherapy; 2017 Oct; 9(13):1115-1125. PubMed ID: 29032733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [allo-CD19-CAR-T cells therapy followed with same-donor allo-HSCT to treat relapsed B-ALL: two cases report and literatures review].
    Li NN; Liu LH; Yang JF; Fan LJ; Gao XX; Yin DX; Lu PH; Zhang JP
    Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):943-945. PubMed ID: 33333700
    [No Abstract]   [Full Text] [Related]  

  • 7. InsT-ALLing CD7 chimeric antigen receptors before transplantation.
    Delgado J
    Br J Haematol; 2024 Jun; 204(6):2155-2156. PubMed ID: 38676290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maintenance therapy following CD19 CAR-T treatment for relapsed B-cell acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation].
    Jiang YL; Li Q; Pu YD; Jiang YY; Yuan T; Deng Q; Li YM; Han MZ; Zhai WH
    Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):495-501. PubMed ID: 32654464
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac involvement in a patient with B-cell lymphoblastic lymphoma/acute lymphoblastic leukemia and a history of allogeneic hematopoietic stem cell transplantation and CAR T-cell therapy: A case report.
    Cao Y; Liu Y; Zhang R; Zhai W; Ma Q; Wei J; Yang D; Pang A; He Y; Chen X; Jiang E; Feng S; Han M
    Front Immunol; 2022; 13():1052336. PubMed ID: 36685607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD7 CAR T bridging to allo-HSCT in R/R T-ALL: A case report.
    Fanqiao M; Chen X; Ren X; Li L; Wu T
    Pediatr Transplant; 2024 May; 28(3):e14367. PubMed ID: 35860981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia.
    Cai B; Guo M; Wang Y; Zhang Y; Yang J; Guo Y; Dai H; Yu C; Sun Q; Qiao J; Hu K; Zuo H; Dong Z; Zhang Z; Feng M; Li B; Sun Y; Liu T; Liu Z; Wang Y; Huang Y; Yao B; Han W; Ai H
    J Hematol Oncol; 2016 Nov; 9(1):131. PubMed ID: 27887660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation.
    Chen YH; Zhang X; Cheng YF; Chen H; Mo XD; Yan CH; Chen Y; Han W; Sun YQ; Wang Y; Zhang XH; Xu LP; Liu KY; Yang J; Zhang J; Zhang GL; Shi Y; Su YC; Li WQ; Xu L; Song D; Zhang M; Lu P; Huang XJ
    Cytotherapy; 2020 Dec; 22(12):755-761. PubMed ID: 32861622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation.
    Cao XY; Li JJ; Lu PH; Liu KY
    Int J Hematol; 2022 Sep; 116(3):315-329. PubMed ID: 35737192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia.
    Chiesa R; Georgiadis C; Syed F; Zhan H; Etuk A; Gkazi SA; Preece R; Ottaviano G; Braybrook T; Chu J; Kubat A; Adams S; Thomas R; Gilmour K; O'Connor D; Vora A; Qasim W;
    N Engl J Med; 2023 Sep; 389(10):899-910. PubMed ID: 37314354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric antigen receptor T cells targeting CD7 in a child with high-risk T-cell acute lymphoblastic leukemia.
    Xie L; Ma L; Liu S; Chang L; Wen F
    Int Immunopharmacol; 2021 Jul; 96():107731. PubMed ID: 33965880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of allogeneic haematopoietic cell transplantation as consolidation after anti-CD19 CAR-T cell therapy in adults with relapsed/refractory acute lymphoblastic leukaemia: a prospective cohort study.
    Han S; Zhou L; Chen Y; Zhou X; Guo Z; Yang J; Jin B; Liu Y; Chang LJ; Li Y; Tu S
    Bone Marrow Transplant; 2022 Mar; 57(3):513-516. PubMed ID: 35058582
    [No Abstract]   [Full Text] [Related]  

  • 17. CAR-T bridging to allo-HSCT as a treatment strategy for relapsed adult acute B-lymphoblastic leukemia: a case report.
    Wen S; Niu Z; Xing L; Wang Y; Li H; Kuang N; Luo J; Zhang X; Wang F
    BMC Cancer; 2018 Nov; 18(1):1143. PubMed ID: 30458755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-matched and HLA-haploidentical allogeneic CD19-directed chimeric antigen receptor T-cell infusions are feasible in relapsed or refractory B-cell acute lymphoblastic leukemia before hematopoietic stem cell transplantation.
    Jin X; Cao Y; Wang L; Sun R; Cheng L; He X; Xiao X; Jiang Y; Li Q; Zhang H; Lu W; Lyu C; Jiang Y; Meng J; Zhao M
    Leukemia; 2020 Mar; 34(3):909-913. PubMed ID: 31628429
    [No Abstract]   [Full Text] [Related]  

  • 19. CD4
    Pan Y; Wang H; An F; Wu F; Tao Q; Li Y; Ruan Y; Zhai Z
    Int Immunopharmacol; 2021 Jul; 96():107742. PubMed ID: 33984717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAR19/22 T cell cocktail therapy for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation.
    Yan N; Wang N; Wang G; Huang L; Li C; Wang D; Wang J; Huang L; Meng F; Wei J; Chen L; Mao X; Zhou J; Zhang Y; Cao Y
    Cytotherapy; 2022 Aug; 24(8):841-849. PubMed ID: 35256277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.